1. Home
  2. AMPL vs PLSE Comparison

AMPL vs PLSE Comparison

Compare AMPL & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPL
  • PLSE
  • Stock Information
  • Founded
  • AMPL 2012
  • PLSE 2014
  • Country
  • AMPL United States
  • PLSE United States
  • Employees
  • AMPL N/A
  • PLSE N/A
  • Industry
  • AMPL EDP Services
  • PLSE Medical/Dental Instruments
  • Sector
  • AMPL Technology
  • PLSE Health Care
  • Exchange
  • AMPL Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • AMPL 1.5B
  • PLSE 1.3B
  • IPO Year
  • AMPL 2021
  • PLSE 2016
  • Fundamental
  • Price
  • AMPL $10.64
  • PLSE $17.07
  • Analyst Decision
  • AMPL Buy
  • PLSE
  • Analyst Count
  • AMPL 10
  • PLSE 0
  • Target Price
  • AMPL $13.50
  • PLSE N/A
  • AVG Volume (30 Days)
  • AMPL 1.0M
  • PLSE 159.2K
  • Earning Date
  • AMPL 05-07-2025
  • PLSE 05-08-2025
  • Dividend Yield
  • AMPL N/A
  • PLSE N/A
  • EPS Growth
  • AMPL N/A
  • PLSE N/A
  • EPS
  • AMPL N/A
  • PLSE N/A
  • Revenue
  • AMPL $306,601,000.00
  • PLSE N/A
  • Revenue This Year
  • AMPL $11.64
  • PLSE N/A
  • Revenue Next Year
  • AMPL $10.90
  • PLSE N/A
  • P/E Ratio
  • AMPL N/A
  • PLSE N/A
  • Revenue Growth
  • AMPL 8.56
  • PLSE N/A
  • 52 Week Low
  • AMPL $7.37
  • PLSE $6.66
  • 52 Week High
  • AMPL $14.88
  • PLSE $25.00
  • Technical
  • Relative Strength Index (RSI)
  • AMPL 64.80
  • PLSE 50.34
  • Support Level
  • AMPL $9.09
  • PLSE $15.92
  • Resistance Level
  • AMPL $10.93
  • PLSE $17.54
  • Average True Range (ATR)
  • AMPL 0.46
  • PLSE 0.93
  • MACD
  • AMPL 0.29
  • PLSE -0.08
  • Stochastic Oscillator
  • AMPL 91.16
  • PLSE 32.58

About AMPL Amplitude Inc.

Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue primarily through selling subscriptions to the platform. The company derives a majority of its revenue from the United States.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: